NeoGenomics Inc. Common Stock vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF — how do they compare? NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.17B), while Vanguard Sht-Term Inflation-Protected Sec Idx ETF trades at $49.94 (market cap $73.20B). The key difference: Vanguard Sht-Term Inflation-Protected Sec Idx ETF is far larger — about 33.7× NeoGenomics Inc. Common Stock's market cap, and Vanguard Sht-Term Inflation-Protected Sec Idx ETF is more actively traded (3,980,495 versus 1,615,943). Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Vanguard Sht-Term Inflation-Protected Sec Idx ETF for 92 Days on average.
| NEO | VTIP | |
|---|---|---|
Market Cap | $2.17B | $73.20B |
Volume | 1,615,943 | 3,980,495 |
Sector | Health | — |
52-Week High | $19.91 | $50.46 |
52-Week Low | $7.19 | $48.38 |
Typical Hold Time | 0 Days | 92 Days |
Enterprise Value | $2.47B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VTIP, the Vanguard Short-Term Inflation-Protected Securities ETF, trades at $48.46, down slightly by 0.06% on the day. The technical picture is bearish based on moving averages, with oscillators neutral. Recent news highlights its role as an inflation hedge amid rising energy prices and Fed rate hikes, with institutional buying noted. Key support is at $48, resistance at $49.
The outlook for VTIP is cautious; it offers inflation protection but faces headwinds from persistent high rates. Risks include interest rate sensitivity and inflation volatility. Analyst sentiment is mixed, with some seeing value in short-duration TIPS, but the bearish technical trend suggests near-term pressure.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →The index is a market-capitalization-weighted index that includes all inflation-protected public obligations issued by the US Treasury with remaining maturities of less than 5 years. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the securities that make up the index, holding each security in approximately the same proportion as its weighting in the index.
Read more on VTIP →